-
2025-522169-31-00
4
2025-10-30
Adult Patients with HER2-IHC3+ selected solid cancers (endometrial, co
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2025-520747-32-00
5
2025-10-29
Mild to moderate Alzheimer’s Disease
-
2023-503283-17-00
6
2025-10-22
Women who delivered by caesarean and have a moderate postpartum iron d
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2023-509728-16-00
4
2025-10-10
advanced Parkinson’s disease
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-520137-74-00
4
2025-10-10
Idiopathic Short Stature (ISS)
-
2025-521147-21-00
4
2025-10-08
Lung Cancer
-
2024-519188-17-00
1
2025-10-07
Relapsed/refractory malignancy with documented diagnosis of human epid
-
2024-511871-13-00
6
2025-10-02
Postmenopausal osteoporosis
-
2024-512177-27-01
5
2025-09-29
High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invas
-
2024-517232-22-00
5
2025-09-26
KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorect
-
2024-519875-24-00
5
2025-09-26
Carcinoid syndrome
-
2024-516804-40-00
6
2025-09-25
Progressive Familial Intrahepatic Cholestasis
-
2024-511989-36-00
5
2025-09-24
Ewing Sarcoma
-
2023-510099-30-00
5
2025-09-23
Out-of-hospital cardiac arrest with initial shockable rhythm
-
2024-520210-21-00
5
2025-09-19
Crohn’s Disease
-
2024-511663-28-00
6
2025-09-11
Asymptomatic Child-Pugh A5 to B8 cirrhosis
-
2024-515241-41-00
4
2025-09-10
Ulcerative Colitis
-
2024-512752-38-00
5
2025-09-09
Adjunctive and maintenance treatment to HCT
-
2024-519152-82-00
5
2025-09-03
Relapsed/Refractory Follicular Lymphoma
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-516437-12-00
9
2025-08-29
Clear cell renal cell carcinoma